Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Mounjaro and Zepbound have not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and are therefore not recommended in these patients. Lilly additionally warned against the use of these products for individuals under the age of 18 years, citing that while clinical trials are ongoing, the safety and efficacy of tirzepatide have not been established in younger patients
What Is Gestational Diabetes
Tirzepatide is a dual GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonist a single molecule that activates two separate hormone receptor systems involved in appetite, metabolism, and blood sugar regulation
J Neurosci 33:1582715836
The 1-month supply is defined as 28 days and 1 KwikPen (or 4 single-dose vials)
Clinical trials for tirzepatide (Zepbound) have shown: Because Zepbound is approved, its outcomes are better understood in real-world and clinical settings
US$ 27.60
US$ 29.45
US$ 29.67
US$ 20.30
